Last update 01 Nov 2024

HLA-A 24 x NY-ESO-1

Basic Info

Related Targets
HLA-A 24NY-ESO-1

Related

3
Drugs associated with HLA-A 24 x NY-ESO-1
UI-5
Target
HLA-A 24 x MAGEA4 x NY-ESO-1
Mechanism
HLA class I antigen A-24 alpha modulators [+2]
Active Org.-
Originator Org.
United Immunity Co. Ltd.United Immunity Co. Ltd.Startup
Active Indication-
Inactive Indication
Head and Neck Neoplasms [+2]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
UI-2
Target
HLA-A 24 x NY-ESO-1
Mechanism
HLA class I antigen A-24 alpha modulators [+1]
Active Org.-
Originator Org.
United Immunity Co. Ltd.United Immunity Co. Ltd.Startup
Active Indication-
Inactive Indication
Castration-Resistant Prostatic Cancer [+1]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
UI-1
Target
HLA-A 24 x NY-ESO-1
Mechanism
HLA class I antigen A-24 alpha modulators [+1]
Active Org.-
Originator Org.
United Immunity Co. Ltd.United Immunity Co. Ltd.Startup
Active Indication-
Inactive Indication
Sarcoma
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with HLA-A 24 x NY-ESO-1
Login to view more data
100 Translational Medicine associated with HLA-A 24 x NY-ESO-1
Login to view more data
0 Patents (Medical) associated with HLA-A 24 x NY-ESO-1
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free